
Furask CV 250mg/125mg Tablet
Marketer
Sakshit Healthcare
Salt Composition
Cefuroxime (250mg) + Clavulanic Acid (125mg)
Overview Furask CV 250mg/125mg Tablet
Combifura 250mg/125mg tablets combat bacterial infections by inhibiting microbial growth and propagation. This prescription medication, taken as directed, can be administered with or without food, but consistent timing maximizes effectiveness. Exceeding the prescribed dosage is unsafe. Missed doses should be taken upon recollection. Complete the entire course of treatment, even with symptom improvement; premature cessation may reduce efficacy. Potential side effects include nausea, vomiting, diarrhea, and dyspepsia; worsening symptoms warrant immediate medical attention. Seek immediate medical help for allergic reactions (rash, pruritus, edema, dyspnea). Inform your physician of all current medications, especially if pregnant or breastfeeding. Alcohol consumption should be avoided due to potential increased drowsiness. While typically non-impairing, driving should be avoided if drowsiness or dizziness occurs. Adequate rest, a nutritious diet, and sufficient hydration promote recovery. Laboratory and diagnostic tests may be ordered to monitor treatment efficacy.
Primary Ingredients of Furask CV 250mg/125mg Tablet
No text provided to rephrase.
Uses of Furask CV 250mg/125mg Tablet
Managing bacterial infections
Major Benefits of Furask CV 250mg/125mg Tablet:
Administer this medication precisely as prescribed by your physician, adhering to both the dosage and treatment schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Furask CV 250mg/125mg Tablets can be consumed with or without food, although consistent timing is recommended.
Common Side effects of Furask CV 250mg/125mg Tablet:
- Nausea
- Vomiting
- Diarrhea
- Increased liver enzymes
- Allergic reaction
How to use Furask CV 250mg/125mg Tablet:
Administer this medication precisely as prescribed by your physician, adhering to both the dosage and treatment duration. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Furask CV 250mg/125mg Tablets can be consumed with or without food, although consistent timing is recommended.
How Furask CV 250mg/125mg Tablet works:
Furask CV 250mg/125mg tablets contain Cefuroxime, an antibiotic, and Clavulanic Acid, a beta-lactamase inhibitor. Cefuroxime combats bacterial infection by disrupting the construction of their protective cell walls, vital for their survival. Clavulanic Acid counteracts bacterial enzymes that would otherwise neutralize Cefuroxime, thus broadening Cefuroxime's effectiveness and overcoming bacterial resistance.
SAFETY ADVICE
AlcoholSAFE
Furask CV 250mg/125mg Tablet use alongside alcohol consumption presents no known adverse reactions.
PregnancySAFE IF PRESCRIBED
The medication Furask CV 250mg/125mg Tablet is typically deemed safe for use during pregnancy. Preclinical trials in animals revealed minimal or no negative consequences for fetal development; nevertheless, clinical data from human studies are scarce.
Breast feedingSAFE IF PRESCRIBED
Furask CV 250mg/125mg tablets are considered safe for use while breastfeeding. Research in humans indicates minimal drug transfer to breast milk, posing no appreciable risk to the infant.
DrivingNOT RELEVANT
Furask CV 250mg/125mg Tablets are restricted to inpatient administration.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the use of Furask CV 250mg/125mg tablets in individuals with renal impairment. Physician consultation is recommended.
LiverCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Furask CV 250mg/125mg tablets to individuals with hepatic impairment. Physician consultation is advised.
What if you forget to take Furask CV 250mg/125mg Tablet :
Should you forget to take a Furask CV 250mg/125mg Tablet, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed tablet and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Furask CV 250mg/125mg Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |
